| Activity Title | Bringing Recent Clinical Findings into the ICU |
| Topic | Sedation |
| Target Audience | Anesthesiologists, surgeons, pulmonologists, intensivists, CRNAs, ICU, CCU, SICU nurses, and hospital pharmacists |
| Accreditation Type | CME/CE |
| Release Date | July 19, 2011 |
| Expiration Date | July 18, 2012 |
| Estimated Time to Complete Activity | 45 Minutes |
LEARNING OBJECTIVES
Upon completion of the activity, participants should be able to:
- Manage adult patients who need sedation and analgesia while receiving ventilator support according to current standards and guidelines
- Use validated scales for sedation, pain, agitation, and delirium in the management of these critically ill patients
- Assess recent clinical findings in sedation and analgesia management and incorporate them into the management of patients in the acute care, procedural, and surgical sedation settings
FACULTY
Richard R. Riker, MD
Director, Critical Care Research
Department of Medicine
Division of Pulmonary and Critical Care Medicine
Maine Medical Center
Portland, Maine
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Complete the CME/CE activity
- (ACPE ONLY) Complete the online posttest. A score of at least 70% is required to successfully complete this activity. The participant may take the test until successfully passed.
- Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
- Your CME/CE certificate will be available for download.
SPONSOR
This activity is sponsored by The France Foundation
 |
TARGET AUDIENCE
This activity is intended for anesthesiologists, surgeons, pulmonologists, intensivists, CRNAs, ICU, CCU, SICU nurses, and hospital pharmacists who manage patients requiring sedation in intensive care and perioperative settings.
STATEMENT OF NEED
Patients in intensive care or undergoing procedures frequently require pain management. Assessment of pain, sedation, agitation, and delirium with validated scales is a critical part of maintaining the balance between oversedation and undersedation. Recent results from patient management trials and from pharmaceutical clinical trials can enhance the practice of sedation and patient outcomes.
ACCREDITATION STATEMENT
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Physicians
The France Foundation designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME-accredited provider.
RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
DISCLOSURE
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty Disclosure
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:
- Richard R. Riker, MD, has served as a consultant for Masimo.
UNAPPROVED USE DISCLOSURE
The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Hospira.
DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Hospira assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2011 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.
